Please try another search
Melinta Therapeutics, LLC, a commercial-stage pharmaceutical company, discovers, develops, and commercializes various anti-infectives for the treatment of bacterial infectious diseases in North America. It offers KIMYRSA (oritavancin), a lipoglycopeptide antibiotic; Orbactiv, an IV antibiotic of the lipoglycopeptide class for the treatment of adult patients with ABSSSIs; Vabomere, an IV antibiotic used in the treatment of gram-negative infections; Minocin, an IV antibiotic of the tetracycline class with activity against gram-positive and gram-negative pathogens; and Baxdela, a monotherapy treatment of adult patients with acute bacterial skin or skin structure infections (ABSSSIs). The company was founded in 2000 and is based in Parsippany, New Jersey with an additional office in Lincolnshire, Illinois.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review